Scientists Receive ??4.3 Million For Pioneering Asthma And Allergy-Prevention Research, London

Posted by poster | Uncategorized | Friday 3 July 2009 1:35 am

Researchers at St George’s, University of London have been awarded ??4.3 million by the Wellcome Trust for the development of a unique new class of drugs to target the root cause of asthma and allergies. The new Allergen Delivery Inhibitors may be superior to existing medicines, which mainly relieve symptoms.
The research team, led by Professor Clive Robinson, has identified novel, drug-like chemical compounds that combat asthma and allergic diseases (more…)

Study Links Depressive Mood, Racial Disparities In Preterm Birth

Posted by poster | Uncategorized | Wednesday 1 July 2009 12:35 am

Buy propecia without prescription Women who have depression symptoms prior to becoming pregnant are at an increased risk for having preterm births, with the risk twice as high for black women as for white women, according to a study in the Journal of Women’s Health, Reuters reports. For the study, Amelia Gavin of the University of Washington and colleagues examined the links between (more…)

Researchers Discover Ways Of Integrating Treatment Of Traumatized Tibetan Refugee Monks

Posted by poster | Uncategorized | Monday 29 June 2009 2:35 am

The Boston Center for Refugee Health and Human Rights (BCRHHR) at Boston Medical Center recently treated many of the large number of Tibetan refugee monks who fled violent religious persecution. These individuals arrived in Boston suffering from symptoms of traumatic stress, interfering with their meditative practice. The monks were diagnosed by their traditional healers as having srog-rLung, a life-wind imbalance. Recognizing that barriers (more…)

Bosentan Is Cost-Effective For Patients With Moderate PAH

Posted by poster | Uncategorized | Saturday 27 June 2009 8:35 pm

Bosentan appears to be a more cost-effective initial treatment option for patients with moderate pulmonary arterial hypertension (PAH), classified as WHO functional class III, than no active intervention.
A cost-utility model was constructed to evaluate the cost-effectiveness of bosentan compared with no active intervention, both added to palliative care in the UK. In the model, simulated patients (more…)

Irritability Should Be Considered When Diagnosing Bipolar Disorder In Children

Posted by poster | Uncategorized | Friday 26 June 2009 7:35 pm

A new study from Bradley Hospital and The Warren Alpert Medical School of Brown University, as well as two other institutions, adds to mounting evidence that clinicians consider irritability as a symptom when diagnosing pediatric bipolar disorder.
Reporting in the July issue of the Journal of the American Academy of Child and Adolescent Psychiatry, researchers say a small percentage of children with bipolar disorder experience manic episodes without extreme (more…)

Next Page »